Mina Han
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
High-dimensional immune profiling of peripheral blood identifies immune correlates of anti-PD-1/PD-L1 resistance in oncogenic driver mutation-positive NSCLC.
Journal: Frontiers in immunology
Published: March 13, 2026
EpCAM+ Extracellular Vesicle PD-L1 Dynamics as a Predictive Biomarker of Immune Checkpoint Blockade Response.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 14, 2026
Circulating Tumor Cell-based Molecular Responses Stratify EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Cancer.
Journal: Cancer research and treatment
Published: June 29, 2025
Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: December 10, 2024
MicroRNA-196a increases apoptosis in B cells through downregulation of FOXO1.
Journal: Molecules and cells
Published: December 09, 2024
A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapy.
Journal: Nature communications
Published: September 25, 2024
CD19/CD22 bispecific chimeric antigen receptor‑NK‑92 cells are developed and evaluated.
Journal: Oncology letters
Published: December 02, 2022
Characteristics of Human Peripheral Blood γδ T Cells Expanded With Zoledronate.
Journal: Anticancer research
Published: September 08, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026